the genetic variants of Mannose-Binding Lectin, a vital component of innate immunity have been studied with acute/recurrent vaginal infections ((R)VVI) and presented inconclusive findings. Therefore, a systematic review and meta-analysis of published data were conducted to assess the possible role of these variations in (R)VVI. A comprehensive search was made using PubMed, Web of Science and Google scholar till June 18, 2019. A total of 12 studies met the specified criteria and were included in the analysis. Different comparisons were made on the basis of the outcome of interest that resulted in the filtering of studies for the pooled analysis to find an association using the standard genetic models. Odds ratio (OR) with 95% confidence interval (CI) was chosen as the effect measure for the data synthesis. The trim and fill technique was applied to adjust the publication bias. The meta-analysis revealed the significant association (p < 0.05) of rs1800450 polymorphism with RVVI risk (OR â„ 3.5) in all the genetic models. The subgroup analysis identified the same association in Caucasian and Mixed ethnicity. Quantitative synthesis based on RVVC showed>3.5 fold risk of disease development accredited to rs1800450. A combined evaluation of Exon1 variants showed no association with (R)VVI. This meta-analysis suggests rs1800450 polymorphism as a genetic predisposing factor for RVVI, but to reinforce, further studies with a larger sample size are warranted. Vulvovaginal infections (VVI) account for a huge fraction of gynaecological outpatient visits by woman of childbearing age and include about 10 to 20% of consultations only. Bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis (TV) are the frequently encountered VVI in clinical practice 1. However, the important issues are their high recurrence rates (RVVI) and the associated severe pregnancy outcomes as well as infectious diseases 2. High proportion of opportunistic pathogens, which are either normally dwelling or transmitted sexually have been suggested as the reason behind the development of VVI and RVVI, collectively abbreviated in this study as (R)VVI 2. Nevertheless, universal presence of asymptomatic cases implies that the shared risk factors of (R)VVI including excessive sexual activity, antibiotics/contraceptives use and ethnicity are simply responsible for increasing the vaginal colonisation of potentially dangerous microbial species but not disease 3. Hence, the presence of symptomatic/asymptomatic (R)VVI cases are mainly accredited to the differences in women's immunity, conferred partially or wholly by genetic variations 1. Therefore, genetic exploration of immune mediators that ultimately decides the host susceptibility to symptomatic (R)VVI is necessary. One such important mediator is human Mannose-Binding Lectin (MBL), which is a vital component of systemic as well as mucosal innate immunity 4. It's a multimeric soluble protein encoded by MBL2 mapped to 10q21.1. Evidences have been provided regarding MBL binding to the molecular pa...